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Summary In this paper an overview is presented on what is currently known of fatigue in cancer. Fatigue is
considered to be a multi-dimensional concept, that should be measured as such. However, fatigue has been
assessed mostly by single items in general symptom checklists. The few specific instruments that have been
used in cancer patient populations are discussed. The majority of cancer patients, about 70%, report feelings
of fatigue during radio- or chemotherapy. Follow-up results show that, at least for some diagnoses, patients
remain fatigued long after treatment has ended. Somatic and psychological mechanisms that have been
proposed to explain fatigue are discussed. It is argued that the significance of the results obtained on fatigue as
a sympton in cancer depends on comparison with other patient and non-patient populations. Also the
occurrence of a response-shift has to be considered, leading to under reporting of fatigue. Finally, possible
interventions to decrease feelings of fatigue are presented.
Cancer and its treatment are characterised by a variety of
possible symptoms such as pain, decreased appetite, ulcers in
the mouth, hair-loss, nausea and vomiting, shortness of
breath, fatigue and a general deterioration of physical condi-
tion. Of all these symptoms, fatigue is without doubt the
symptom most commonly experienced. It can be the first
manifestation of an underlying disease process. Subsequent
treatment with surgery, radio- or chemotherapy may induce
or worsen feelings of fatigue. The final stages of the disease
process are often characterised by exhaustion and a complete
loss of energy. The consequences of fatigue are reflected in its
detrimental effects on patients quality of life (Achard &
Zitoun, 1991), self-care activities (Rhodes et al., 1988) and
social activities (Cristensen, 1989).
To date there are few studies which systematically register
how many cancer patients experience fatigue, in which stage
of the disease process and to what extent. To give an indica-
tion, a literature-search using MEDLINE with CD-ROM
over the period 1980 to 1991 yielded nine references in which
'fatigue' was included in the title and 'cancer' was included in
title, keyword or abstract. Eight of these references pertained
to nursing research.
An appraisal of the research literature concerning fatigue
in cancer is presented in this paper to give an overview of
what is currently known. Literature, other than obtained
using the MEDLINE-procedure, was gathered either by sear-
ching for studies in which fatigue was assessed as part of
patient functioning or through references of the papers
obtained. This procedure does evidently not lead to an
exhaustive list of all the studies which included fatigue as an
outcome-variable. However, we think to have obtained a
representative sample. Topics that will be discussed are: the
conceptualisation of fatigue and its measurement, prevalence
rates of fatigue during and after treatment and somatic and
psychological correlates of fatigue. Finally, considerations
with regard to research and interventions will be discussed.
The concept of fatigue
A fundamental but difficult question is what fatigue in cancer
means and how it can be defined or described. It is beyond
the scope of this article to present a theoretical framework on
the concept of fatigue. However, an impression can be given
on some of the ways in which the term has been used. The
concept seems clear in everyday use. The most common
meaning is tiredness after physical exercise, when it is de-
scribed in terms of muscles which can hardly be used or are
aching. The term is also used to describe the feeling state
after mental effort, referring to reluctance in further mental
effort, concentration problems and deficits in cognitive func-
tioning. The condition of not arriving at any useful activities
is sometimes labelled as fatigue too. Another meaning is not
feeling motivated to develop activities.
Without specification of its exact meaning, fatigue is
reported as a symptom of many other diseases including
multiple sclerosis and systemic lupus erythematosus, myocar-
dial infarction, renal disease, the Chronic Fatigue Syndrome
and lung-emphysema (Appels & Mulder, 1988; Krupp et al.,
1989; Srivastava, 1989). Fatigue is also universally considered
to be a symptom of depression.
In addition to a symptom of a somatic or psychological
condition, fatigue might also be conceived as a mood-state.
Moods in general have been described as states of action
readiness or action preparedness. Consequently, fatigue has
been described as a mood-state characterised by de-activation
or low-action-preparedness (Frijda, 1986).
The reduced performance resulting from long or intense
cognitive or physical functioning, which may suggest a simple
cause effect relationship, has traditionally been equivalent to
fatigue in occupational psychology. However, reports of
fatigue appear to depend heavily on being motivated to
adequate performance. Therefore, fatigue has more recently
been described as a lack of motivation to perform (Meyman,
1991).
Finally, fatigue has been thought of as either an acute or a
chronic phenomenon. Not only are there differences in
causative and maintaining factors for the acute or chronic
fatigue, but the description of these experiences may also
differ.
The foregoing implicates that fatigue is a multidimensional
concept with several modes of expression: physical, cognitive,
in activity or in motivation, acute or chronic. Which of these
aspects describes the fatigue experience of cancer patients
best is currently unknown.
Measurement of fatigue
Assuming that fatigue is a multi-dimensional concept, the
question is how it has been assessed in cancer patients. It has
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been measured most of the time by single items in general
symptom checklists such as the Symptom Distress Scale
(McCorkle & Quint, 1983; Oberst et al., 1991), the Symptom
Profile (King et al., 1985), the Rotterdam Symptom Checklist
(de Haes et al., 1990) or by the 'fatigue' subscale of the
Profile of Mood States (POMS) (Spiegel et al., 1981).
More specific instruments have been used to assess fatigue
in cancer patient populations. These can be divided in one-
dimensional or multidimensional instruments. The simplest
one-dimensional measure of tiredness is the Rhoten Fatigue
Scale (RFS), in which a visual analogue scale is combined
with a numerical ten points rating scale, ranging from 'not
tired, full of energy' to 'total exhaustion' (Rhoten, 1982;
Blesch et al., 1991). Pearson and Byars (1956) developed a
ten item Fatigue Feeling Checklist (PBFFC), that was used
in studies on the effects of radiotherapy (Haylock & Hart,
1979) and chemotherapy (Cristensen, 1989). This instrument
contains ten adjectives, ranging from 'extremely peppy' to
'extremely tired'. Estimates of reliability and validity are
lacking (Piper, 1988).
The Fatigue Symptom Checklist (FSCL) is a multidimen-
sional questionnaire, aiming to assess fatigue in a work situa-
tion (Kogi et al., 1970). It was used by Haylock and Hart
(1979) and by Kobashi and co-workers (Kobashi et al., 1985)
in a study on radiotherapy patients. The original FSCL
contains 30 symptoms and was divided into three subscales
based on a factor analysis::(1) general feelings of sleepiness,
with items like 'feel tired in the legs' and 'want to lie down',
(2) mental feelings of fatigue, with items like 'difficulty in
thinking' and 'become nervous', and (3) specific bodily sensa-
tions, with items like 'headache' and 'dizziness'. Factor
analysis on the Dutch version of the FSCL resulted in a three
factor solution with an item distribution which differed from
the original subscales. A physical fatigue scale, a mental
fatigue scale and a malaise scale were distinguished (Kobashi
et al., 1985).
Piper and colleagues set out to develop an instrument to
measure the experience of fatigue of patients, the Piper
Fatigue Self-report Scale (PFS) (Piper et al., 1989). The total
fatigue score is calculated on the basis of the scores from
four subscales representing the temporal, intensity, affective
and sensory dimensions of fatigue. Based on the results in a
sample of breast and lung cancer patients who started their
first week of radiation, the authors concluded that the PFS
shows excellent reliability (a Cronbach's Alpha of 0.85) and
moderate construct validity. However, a large percentage of
patients had troubles filling in the questionnaire. Also, no
mention was made whether the assumed dimensions of
fatigue were reflected in the actual data of the patient
population.
In conclusion, most measures of fatigue in cancer are
incorporated in instruments that measure broader aspects of
patient functioning. A more comprehensive instrument,
thoroughly tested for its psychometric properties, is not yet
available.
The prevalence of fatigue in cancer
According to studies which applied general symptom check-
lists that contain items asking about fatigue, tiredness or loss
of energy, the following estimate of the prevalence of fatigue
in cancer is obtained.
In a study in which patients were interviewed weekly dur-
ing radiation treatment and monthly for 3 months after
treatment had ended, fatigue was the only symptom
experienced by the majority of patients in all diagnostic
groups (King et al., 1985). The highest frequency of fatigue
was 93% for patients irradiated on the chest, 68% for head
and neck cancer patients, 65% for male genitourinary tract
cancer patients, and 72% for gynaecologic cancer patients.
Other studies involving cancer patients who receive external
radiation also identified fatigue or tiredness as a frequently
reported symptom (Mitchell & Glicksman, 1977; Peck &
Boland, 1977; McCorkle & Quint, 1983; Andersen & Tewfik,
1985; Oberst et al., 1991). Chemotherapy also results in a
high incidence of fatigue. Prevalence rates between 75% and
100% of tiredness during chemotherapy have been reported
(Linssen et al., 1979; Nerenz et al., 1982; Cassileth et al.,
1985; de Haes et al., 1987; Nail & King, 1987; Love et al.,
1989). Finally, feelings of tiredness are characteristic for the
period of convalescence after surgery (Christensen et al.,
1982).
Follow-up results show that, at least for some diagnoses,
many patients remain fatigued after treatment has ended.
Devlen et al. (1987) examined 120 newly diagnosed patients
with Hodgkin's or non-Hodgkin's disease in a prospective
study. Although most patients were no longer receiving treat-
ment and were free of disease at a one year follow-up, 42%
of these patients continued to complain of loss of energy and
32% of tiredness. In a survey among members of the patient-
organisation of Hodgkin and non-Hodgkin patients (Breij &
Visser, 1990), 61% of the subjects reported fatigue that was
described as 'moderate to quite bad'. Treatment had ended
more than 2 years prior to the survey in 60% of the sample.
Berglund et al. (1991) assessed late effects of adjuvant treat-
ment on perceived health of breast cancer patients, free from
recurrence 2 to 10 years after primary therapy. Patients who
had received radiotherapy reported decreased stamina (75%)
more frequently than did chemotherapy patients (61%).
Finally, the psychological problems that develop in long term
survivors of Hodgkin's disease were examined in a cross-
sectional survey of 403 patients (Fobair et al., 1986). The
median time since treatment was 9 years. Results indicated
that energy had not returned to patients' satisfaction in 37%
of the cases.
In the foregoing studies, single items were used to assess
fatigue. Instruments specifically developed to measure fatigue
were used in the studies discussed next. Three studies have
assessed the fatigue experience of patients receiving
radiotherapy. Haylock and Hart (1979) used the PBFFC and
FSCL to assess the daily experienced fatigue level and fatigue
symptoms of 30 patients. The results indicated an increase in
fatigue scores over the course of radiation. Those patients
who underwent the most lengthy treatment regimens showed
the greatest increase in their fatigue levels. A consistent
decline in fatigue occurred on Sundays throughout the entire
course of therapy, which was apparently related to the
absence of treatment over the weekends. In another study in
which the FSCL was used, the fatigue experience of 106
patients with a variety of diagnoses was assessed during
radiotherapy treatment (Kobashi et al., 1985). The findings
of Haylock and Hart were replicated. A significant increase
in physical fatigue symptoms and feelings of malaise were
demonstrated over the course of treatment, and a 'weekend
effect' was noted for patients with malignant lymphoma and
those with uterine cancer, but not for patients with cancer of
the breast or urinary bladder. Chin et al. (1990) interviewed
patients prior to, during and 2 weeks after the end of their
radiation treatment. Patients were divided into four groups
according to the field of radiation: (1) head and neck (2)
chest (3) abdomen and (4) extremities. Of the head and neck
patients 48% reported fatigue, with increasing intensity over
the course of treatment. Of the thorax patients, 69% com-
plained of increasing fatigue. The highest percentage of
fatigue (72%) was reported by the group radiated on the
abdomen. None of the patients in the fourth group reported
fatigue.
There is even less systematic research on the fatigue
experienced by individuals receiving chemotherapy. In an
exploratory study data were collected with the PBFFC of 16
women who were receiving chemotherapy for treatment of
ovarian cancer (Jamar, 1989). Twelve of these women
(75%) reported that fatigue was worse the first week follow-
ing chemotherapy but lessened during the subsequent 3
weeks of the cycle. A decline in fatigue-scores after the
drug-administration period was also reported by Pickard
(1991).
In summary, the majority of cancer patients, about 70%
report feelings of tiredness and fatigue during radio- and222 E.M.A. SMETS et al.
chemotherapy. The intensity of these feelings of fatigue in-
creases over the course of treatment. Indications are that
some patients continue to experience a lack of energy after
treatment has ended but follow-up results show large
differences in prevalence rates. Finally, the experience of
fatigue appears to be treatment related as reflected by the
variation in prevalence rates between groups with different
radiation fields, and by the reduction in fatigue-scores during
periods without treatment.
Factors related to cancer fatigue
The mechanisms that produce fatigue are unknown. Sugges-
tions have been made of a relationship between fatigue and
the consequences of the illness. The finding that prevalence
rates vary according to treatment site or moment of treat-
ment, support the assumed importance of treatment related
factors.
The following somatic mechanisms for fatigue have been
proposed in patients with active disease or during treat-
ment.
Malnutrition has been associated with fatigue, resulting
from anorexia, changes in metabolism, obstructions,
vomiting, diarrhoea or swallowing difficulties (Campbell et
al., 1984; Yasko & Greene, 1987). Malnutrition may cause
abnormal muscle function because of a lack or an imblance
of essential metabolites, and because of a loss of muscle
mass.
Haylock and Hart (1979) mention the possibility that
fatigue is caused by the accumulation of cell destruction end
products and toxic metabolites inhibiting normal cell function-
ing.
Cancer patients, particularly when treated with
chemotherapy, run a high risk of developing infections - and
the fatigue that goes with it - because of immunosuppression
(Yasko & Greene, 1987; Bruera & MacDonald, 1988).
Also, anaemia is frequently mentioned as a possible factor
in fatigue. However, a correlation between fatigue and the
degree of anaemia is rarely found (Piper et al., 1987).
Anaemia is probably only a factor with regard to fatigue
when haemoglobin levels are extremely low (Bruera & Mac-
Donald, 1988).
Day-time tiredness can be induced by drugs with a sedative
(main or side) effect, including anti-emetics, analgesics or
sleeping-agents (Aistars, 1987). Tiredness can also result from
insomnia, which is a common problem of cancer patients
(McCorkle & Quint, 1983; Cannici et al., 1983; Kaye et al.,
1983; Silberfarb et al., 1985). Among other things, difficulty
getting to sleep and difficulty staying asleep might result from
pain. A significant correlation (r = .48 P<.0001) has been
found between the severity of pain and the intensity of
fatigue (Blesch et al., 1991). Finally, it was made plausible
that Immobilisation was an important factor for a post-
operative increase in heart rate during exercise which was
significantly related to an increase in reports of fatigue
(Christensen et al., 1982; Zeiderman et al., 1990).
To our knowledge, no one has yet addressed the issue of
which somatic mechanisms might contribute to persistent
fatigue after cancer-treatment, when no symptoms of disease
can be found. Except for drug-use and insomnia, none of the
somatic factors presented seems relevant for the explanation
of this chronic fatigue.
When discussing the etiology of fatigue, many authors
mention the possible influence of psychological factors.
Depression in particular is considered to be a contributor to
fatigue in cancer. Feelings of depression may result from the
fact that one has a possibly fatal disease, and a depressed
state of mind may induce fatigue. However, depression could
not only be a cause, but also a result ofpersistent feelings of
tiredness. Loss of function, loss of energy resulting directly
from illness or its treatment may have this adverse
psychological consequence. Finally, in cancer depression and
fatigue may co-occur because both result from the same
biological factors (Hayes, 1991).
As yet, no systematic studies have been performed to
investigate the relationship between depression or anxiety
and fatigue experienced by cancer patients. However, most
study results suggest a relation between negative affect and
fatigue. Preliminary results indicate that patients themselves
notice a relation between psychological patterns and their
fatigue experience (Piper, 1990). Women receiving treatment
for breast cancer were asked what they believed contributed
most directly to or caused their fatigue. Their answers
indicated that changes in psychological patterns such as in-
creased stress, worry, depression and anxiety contributed to
fatigue most. Fatigue was found to be significantly related to
mood (Cristensen, 1989; Blesch et al., 1991). Nerenz et al.
(1982) found tiredness to be strongly associated with the
emotional distress experienced during chemotherapy treat-
ment. Finally, patients whose energy level had not returned
to normal after treatment for Hodgkin's disease, were also
more likely to have elevated depression scores (Fobair et al.,
1986).
Research issues
From the foregoing it can be concluded that research in the
domain of fatigue in cancer is only in its infancy. Further
research has to address issues such as (a) prevalence rate of
fatigue at different stages of the disease, including follow-up
data after successful treatment (b) the somatic, behavioral
and psychological correlates of fatigue and (c) the conse-
quences of this particular symptom for the well-being of the
patient.
An important omission in most research on cancer fatigue
is the lack of comparison-groups (Irvine et al., 1991). To be
able to determine the significance of the results obtained, the
prevalence and intensity of fatigue in cancer patients need to
be compared with the prevalence and intensity of fatigue in
patients with other diseases or with non-patient populations.
Prevalence rates between 14 and 34% of tiredness have been
found in community surveys (Chen, 1986; Rillsdale, 1991).
This means that the prevalence rates of fatigue in cancer
patients should be rather high, to justify the conclusion that
patients differ in their fatigue experience from the general
population. Pickard et al. (1991) did compare the fatigue
scores of women receiving chemotherapy for ovarian cancer,
with the scores a convenience sample of apparently healthy
adult women. The difference between the mean fatigue scores
of both groups did not reach significance. This lack of
difference may be explained satisfactorily by the small sam-
ples used in this study.
However, there is another possible explanation for the
similarity in fatigue scores of patients and non-patients.
When comparing the fatigue scores of cancer patients with
those of other populations, or when comparing fatigue scores
obtained before treatment with those obtained after treat-
ment, an interpretation problem arises; the problem of a
(response shift' having occurred in the sample of cancer
patients. The term 'response shift' refers to the change in a
person's internal standard for determining his or her level of
functioning on a given dimension (Breetvelt & van Dam,
1991). This shift in standard may result from a training
course, an intervention or a major life-event. The experience
of fatigue during radio- or chemotherapy, could change a
patient's standard of measurement concerning fatigue. What
has been perceived to be 'intense' fatigue before treatment,
might be labelled 'slightly' fatigued after having experienced
exhaustion during treatment. The possible occurrence of a
'response shift' complicates the interpretation of comparison
data. These interpretation problems have been described in
studies evaluating the effectiveness of training or therapy
interventions. In this field of study methods have been
recommended to ascertain whether a 'response shift' has
occurred. Howard et al. (Breetvelt & Van Dam, 1991)
advocated the use of 'then'-ratings, on which subjects
indicated, in retrospect after the treatment, how they rated
their functioning before treatment. As the 'then' pre-FATIGUE IN CANCER PATIENTS 223
treatment scores were assessed at the same time as the post-
treatment scores, it is probable that these scores were
assigned from the same perspective and therefore are free
from 'response shift' bias. Further research has to indicate
the applicability of techniques for the assessment of a 're-
sponse shift' with regard to symptom reporting.
Concluding remarks
The hope is that good measurement and a better understand-
ing of the course and correlates of fatigue may result in
recommendations for interventions. These recommendations
would then require systematic testing in populations of
cancer patients. At this moment we can only speculate about
possible beneficial interventions. Results have indicated that
patients do no always expect fatigue to be a side-effect of
treatment (Cassileth et al., 1985; Love et al., 1989; Tierney et
al., 1991). Preparatory information on what to expect in
terms of fatigue during and after treatment, could enhance
the ability of patients to cope with this symptom. Good
information may also prevent unnecessary worries about
fatigue indicating tumour growth or treatment failure.
In healthy individuals it is generally assumed that exercise
is effective in reducing fatigue. So far, this assumption has
been tested with cancer patients in preliminary studies only
(Questad, 1983; McVicar & Winningham, 1984; Young &
Sexton, 1991). Due to limitations of these studies no firm
conclusions can be drawn. However, the results obtained are
promising enough to stimulate further research.
The expectation as to the effect of physical exercise has
been attributed a role in the maintenance of fatigue (Wessely
et al., 1990). Anticipating fatigue with certain activities, will
lead to avoidance. Such an anticipation may be based on one
or a few negative experiences, for instance after a too
enthusiastic start of activities in the early phase of con-
valescence. Avoidance makes the person unfit, leading to
easy development of fatigue when physical exercise is again
undertaken.
Finally, studies evaluating the effectiveness of a
psychotherapeutic intervention for cancer patients have
found decreased fatigue-scores as a result of these interven-
tions (Spiegel et al., 1981; Forester et al., 1985; Fawzy et al.,
1990). Therefore interventions aimed at reducing emotional
distress or enhance coping responses may also be an effective
way to decrease feelings of fatigue.
Further research might give information on those factors
that differentiate between patients for whom the fatigue is in
part the result of psychological or behavioral factors, from
those patients whose fatigue is mainly somatic in origin.
Being able to differentiate means that the interventions
offered can be more customised to the needs ofthe individual
patient.
At this moment no other conclusion remains then that our
knowledge of fatigue as experienced by cancer patients is
limited. Much research will be needed to clarify the
undoubtedly complex somatic and psychological mechanisms
responsible for the development, maintenance and treatment
of fatigue.
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